Strong Balance Sheet Stocks

Results

3580

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

3580 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	RADA	US$9.87	-2.4%	5.0%	US$490.9m	US$14.00	85.0	83.7%	n/a	Capital Goods
	FFHL	US$8.30	0.7%	8.1%	US$27.1m	n/a	2.8	n/a	n/a	Materials
	PBIP	US$15.13	-0.7%	9.6%	US$117.7m	US$15.00	1.0	87.9%	1.9%	Banks
	BKFG	US$94.00	0%	n/a	US$54.8m	n/a	6.8	n/a	n/a	Diversified Financials
	ORPB	US$11.18	0%	41.7%	US$80.3m	n/a	1.0	n/a	n/a	Banks
	WBHC	US$1,500.00	0%	n/a	US$18.4b	n/a	31.0	n/a	0.2%	Banks
	KEWL	US$50.70	0.3%	68.2%	US$57.1m	n/a	117.3	n/a	n/a	Materials
	PFBX	US$22.95	0%	16.2%	US$106.0m	n/a	1.0	n/a	1.6%	Banks
	BLBD	US$73.99	1.6%	72.6%	US$2.3b	US$81.71	17.6	14.9%	n/a	Capital Goods
	GRVY	US$65.52	15.9%	5.8%	US$455.3m	n/a	9.3	n/a	n/a	Media
	EBMT	US$22.91	-1.1%	48.3%	US$179.3m	US$23.50	0.9	4.6%	2.5%	Banks
	TRVI	US$17.21	17.4%	199.3%	US$2.4b	US$23.90	14.2	-6.5%	n/a	Pharmaceuticals & Biotech
	ATRC	US$28.80	2.9%	-9.7%	US$1.5b	US$47.00	2.6	51.0%	n/a	Healthcare
	GSBX	US$37.92	0%	n/a	US$87.3m	n/a	1.0	n/a	n/a	Banks
	SLN	US$6.93	-1.0%	20.1%	US$327.3m	US$31.20	390.1	-27.2%	n/a	Pharmaceuticals & Biotech
	AUBN	US$25.40	1.8%	17.1%	US$88.7m	n/a	1.0	n/a	4.3%	Banks
	BRNS	US$0.66	-5.5%	-25.5%	US$27.0m	US$5.50	0.4	n/a	n/a	Pharmaceuticals & Biotech
	III	US$4.01	-2.0%	-14.3%	US$191.8m	US$6.67	18.2	17.6%	4.5%	Software
	MRLN	US$6.69	-4.3%	-35.5%	US$645.7m	US$13.00	84.0	108.5%	n/a	Capital Goods
	CZWI	US$21.34	2.3%	64.8%	US$205.8m	US$24.00	1.1	20.3%	2.0%	Banks
	GHRS	US$22.24	9.2%	90.4%	US$1.5b	US$39.50	5.8	3.9%	n/a	Pharmaceuticals & Biotech
	SNT	US$2.22	-7.9%	-53.8%	US$51.8m	n/a	37.9	n/a	n/a	Tech
	SEPN	US$36.17	0.4%	243.5%	US$1.6b	US$45.78	22.6	-32.4%	n/a	Pharmaceuticals & Biotech
	NTLA	US$15.67	5.0%	69.8%	US$2.2b	US$26.63	33.1	67.0%	n/a	Pharmaceuticals & Biotech

Page 1 of 100